Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 100
- Avg volume
- —
- Day's range
- $12.99 – $12.99
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
As of September 22, 2025, Denali Capital Acquisition Corp. was acquired by Semnur Pharmaceuticals, Inc., in a reverse merger transaction. Denali Capital Acquisition Corp. does not have significant operations. It intends to affect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses in technology, consumer, and hospitality sectors. The c...
Show more
As of September 22, 2025, Denali Capital Acquisition Corp. was acquired by Semnur Pharmaceuticals, Inc., in a reverse merger transaction. Denali Capital Acquisition Corp. does not have significant operations. It intends to affect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses in technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 646 978 5180
- Address
- 437 Madison Avenue, 27th Floor, New York, United States
Latest news
No headlines yet.
